SEARCH
= Paid-up subscribersLockyer M. Diabetes therapy and bladder cancer risk. Practitioner 2016;260 (1797):8
Diabetes therapy and bladder cancer risk
24 Oct 2016
A UK population-based cohort study concludes that pioglitazone is associated with an increased risk of bladder cancer in patients with type 2 diabetes.
This article can only be accessed if you are a registered user of thepractitioner.co.uk or a subscriber to The Practitioner.